Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]

Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773—781. Page 775, left column, third paragraph, line 4, the text “(p<0.5)” should read “(p<0.05)”. Page 775, left column, second line from the bottom, the text &...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hisanaga K, Uchino H, Kakisu N, Miyagi M, Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	immune checkpoint inhibitor diabetes overall survival progression-free survival Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/e2d95d3f51214e5e8c9da4e051790227
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e2d95d3f51214e5e8c9da4e051790227
record_format	dspace
spelling	oai:doaj.org-article:e2d95d3f51214e5e8c9da4e0517902272021-12-02T15:24:23ZPre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]1178-7007https://doaj.org/article/e2d95d3f51214e5e8c9da4e0517902272021-07-01T00:00:00Zhttps://www.dovepress.com/corrigendum-pre-existing-diabetes-limits-survival-rate-after-immune-ch-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773—781. Page 775, left column, third paragraph, line 4, the text “(p<0.5)” should read “(p<0.05)”. Page 775, left column, second line from the bottom, the text “11.3±20.8” should read “113.0±20.8”. Page 776, Table 1, Plasma glucose (mg/dl) row, Unmatched, Non-DM (n=64) column, the value “11.3±20.8” should read “113.0±20.8”. The authors apologize for these errors. Read the original articleHisanaga KUchino HKakisu NMiyagi MYoshikawa FSato GIsobe KKishi KHomma SHirose TDove Medical Pressarticleimmune checkpoint inhibitordiabetesoverall survivalprogression-free survivalSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 3109-3110 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	immune checkpoint inhibitor diabetes overall survival progression-free survival Specialties of internal medicine RC581-951
spellingShingle	immune checkpoint inhibitor diabetes overall survival progression-free survival Specialties of internal medicine RC581-951 Hisanaga K Uchino H Kakisu N Miyagi M Yoshikawa F Sato G Isobe K Kishi K Homma S Hirose T Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
description	Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773—781. Page 775, left column, third paragraph, line 4, the text “(p<0.5)” should read “(p<0.05)”. Page 775, left column, second line from the bottom, the text “11.3±20.8” should read “113.0±20.8”. Page 776, Table 1, Plasma glucose (mg/dl) row, Unmatched, Non-DM (n=64) column, the value “11.3±20.8” should read “113.0±20.8”. The authors apologize for these errors. Read the original article
format	article
author	Hisanaga K Uchino H Kakisu N Miyagi M Yoshikawa F Sato G Isobe K Kishi K Homma S Hirose T
author_facet	Hisanaga K Uchino H Kakisu N Miyagi M Yoshikawa F Sato G Isobe K Kishi K Homma S Hirose T
author_sort	Hisanaga K
title	Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
title_short	Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
title_full	Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
title_fullStr	Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
title_full_unstemmed	Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
title_sort	pre-existing diabetes limits survival rate after immune checkpoint inhibitor treatment for advanced lung cancer: a retrospective study in japan [corrigendum]
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/e2d95d3f51214e5e8c9da4e051790227
work_keys_str_mv	AT hisanagak preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT uchinoh preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT kakisun preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT miyagim preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT yoshikawaf preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT satog preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT isobek preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT kishik preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT hommas preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum AT hiroset preexistingdiabeteslimitssurvivalrateafterimmunecheckpointinhibitortreatmentforadvancedlungcanceraretrospectivestudyinjapancorrigendum
_version_	1718387298311077888

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]

Ejemplares similares